Oxytocin, a new determinant of bone mineral density in post-menopausal women: Analysis of the OPUS cohort

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 4, 2014, Pages

  Breuil, Véronique ^a,b   Panaia Ferrari, Patricia ^c   Fontas, Eric ^d   Roux, Christian ^e   Kolta, Sami ^e   Eastell, Richard ^f   Ben Yahia, Hedi ^a,c,g,h   Faure, Sylvie ^c   Gossiel, Fatma ^f   Benhamou, Claude Laurent ⁱ   Euller Ziegler, Liana ^a,b   Amri, Ez Zoubir ^b,g,h  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^b UNIVERSITÉ CÔTE D'AZUR   (France)

^c University Hospital of Nice University of Nice Sophia Antipolis   (France)

^d UNIVERSITY HOSPITAL OF NICE   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f UNIVERSITY OF SHEFFIELD   (United Kingdom)

^g CNRS   (France)

^h CENTRE DE BIOCHIMIE   (France)

ⁱ CENTRE HOSPITALIER RÉGIONAL D ORLÉANS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; CARBOXY TERMINAL TELOPEPTIDE; COLLAGEN; ESTRADIOL; LEPTIN; OXYTOCIN; PROCOLLAGEN TYPE 1 AMINO TERMINAL PROPEPTIDE; UNCLASSIFIED DRUG;

AGED; ARTICLE; BONE DENSITY; BONE REMODELING; BONE TURNOVER; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; FRAGILITY FRACTURE; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; OSTEOPENIA; PATHOPHYSIOLOGY; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL;

AGED; BIOLOGICAL MARKERS; BONE DENSITY; BONE REMODELING; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; FRACTURES, BONE; HUMANS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; OXYTOCIN; POSTMENOPAUSE; PROGNOSIS;

EID: 84898462236     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-4126     Document Type: Article

References (31)

1. Gimpl G, Fahrenholz F. The oxytocin receptor system: structure, function, and regulation. Physiol Rev . 2001;81:629-683.
2. Nomura M, McKenna E, Korach KS, Pfaff DW, Ogawa S. Estrogen receptor- regulates transcript levels for oxytocin and arginine vasopressin in the hypothalamic paraventricular nucleus of male mice. Brain Res Mol Brain Res. 2002;109:84-94.
3. Choleris E, Gustafsson JA, Korach KS, Muglia LJ, PfaffDW,Ogawa S. An estrogen-dependent four-gene micronet regulating social recognition: a study with oxytocin and estrogen receptor- and- knockout mice. Proc Natl Acad Sci USA . 2003;100:6192-6197.
4. Amico JA, Seif SM, Robinson AG. Oxytocin in human plasma: correlation with neurophysin and stimulation with estrogen. J Clin Endocrinol Metab . 1981;52:988-993.
5. Honda K, Narita K, Murata T, Higuchi T. Leptin affects the electrical activity of neurones in the hypothalamic supraoptic nucleus. Brain Res Bull . 2002;57:721-725.
6. Yamamoto S, Morimoto I, Kai K, et al. Centrally administered murine leptin stimulates plasma arginine-vasopressin secretion and increases the level of mRNA expression in the supraoptic nucleus of conscious rats. Neuroendocrinology . 1999;70:207-212.
7. Zagoory-Sharon O, Schroeder M, Levine A, Moran TH, Weller A. Adaptation to lactation in OLETF rats lacking CCK-1 receptors: body weight, fat tissues, leptin and oxytocin. Int J Obes (Lond) . 2008;32:1211-1221.
8. Sirotkin AV, Mlyncek M, Kotwica J, Makarevich AV, Florkovicova I, Hetenyi L. Leptin directly controls secretory activity of human ovarian granulosa cells: possible inter-relationship with the IGF/ IGFBP system. Horm Res . 2005;64:198-202.
9. Copland JA, Ives KL, Simmons DJ, Soloff MS. Functional oxytocin receptors discovered in human osteoblasts. Endocrinology . 1999; 140:4371-4374.
10. Colucci S, Colaianni G, Mori G, Grano M, Zallone A. Human osteoclasts express oxytocin receptor. Biochem Biophys Res Commun . 2002;297:442-445.
11. Elabd SK, Sabry I, Hassan WB, Nour H, Zaky K. Possible neuroendocrine role for oxytocin in bone remodeling. Endocr Regul . 2007; 41:131-141.
12. Elabd C, Basillais A, Beaupied H, et al. Oxytocin controls differentiation of human mesenchymal stem cells and reverses osteoporosis. Stem Cells . 2008;26:2399-2407.
13. Tamma R, Colaianni G, Zhu LL, et al. Oxytocin is an anabolic bone hormone. Proc Natl Acad Sci USA . 2009;106:7149-7154.
14. Breuil V, Amri EZ, Panaia-Ferrari P, et al. Oxytocin and bone remodelling: relationships with neuropituitary hormones, bone status and body composition. Joint Bone Spine . 2011;78:611-615.
15. Lawson EA, Holsen LM, Santin M, et al. Oxytocin secretion is associated with severity of disordered eating psychopathology and insular cortex hypoactivation in anorexia nervosa. J Clin Endocrinol Metab . 2012;97:E1898-E1908.
16. Gluer CC, Eastell R, Reid DM, et al. Association of five quantitative ultrasound devices and bone densitometry with osteoporotic vertebral fractures in a population-based sample: theOPUSStudy. J Bone Miner Res . 2004;19:782-793.
17. Genant HK, Grampp S, Gluer CC, et al. Universal standardization for dual x-ray absorptiometry: patient and phantom cross-calibration results. J Bone Miner Res . 1994;9:1503-1514.
18. Lu Y, Fuerst T, Hui S, Genant HK. Standardization of bone mineral density at femoral neck, trochanter and Wards triangle. Osteoporos Int . 2001;12:438-444.
19. ONeill TW, Cooper C, Cannata JB, et al. Reproducibility of a questionnaire on risk factors for osteoporosis in a multicentre prevalence survey: the European Vertebral Osteoporosis Study. Int J Epidemiol . 1994;23:559-565.
20. Szeto A, McCabe PM, Nation DA, et al. Evaluation of enzyme immunoassay and radioimmunoassay methods for the measurement of plasma oxytocin. Psychosom Med . 2011;73:393-400.
21. Liu X, Shimono K, Zhu LL, et al. Oxytocin deficiency impairs maternal skeletal remodeling. Biochem Biophys Res Commun . 2009; 388:161-166.
22. Lawson EA, Ackerman KE, Estella NM, et al. Nocturnal oxytocin secretion is lower in amenorrheic athletes than nonathletes and associated with bone microarchitecture and finite element analysis parameters. Eur J Endocrinol . 2013;168:457-464.
23. Lawson EA, Donoho DA, Blum JI, et al. Decreased nocturnal oxytocin levels in anorexia nervosa are associated with low bone mineral density and fat mass. J Clin Psychiatry . 2011;72:1546-1551.
24. McCullough ME, Churchland PS, Mendez AJ. Problems with measuring peripheral oxytocin: can the data on oxytocin and human behavior be trusted? Neurosci Biobehav Rev. 2013;37(8):1485-1492.
25. Finigan J, Gossiel F, Gluer CC, et al. Endogenous estradiol and the risk of incident fracture in postmenopausal women: theOPUSstudy. Calcif Tissue Int . 2012;91:59-68.
26. Cummings SR, Browner WS, Bauer D, et al. Endogenous hormones and the risk of hip and vertebral fractures among older women. Study of Osteoporotic Fractures Research Group. N Engl J Med . 1998;339:733-738.
27. Ettinger B, Pressman A, Sklarin P, Bauer DC, Cauley JA, Cummings S.R. Associations between low levels of serum estradiol, bone density, and fractures among elderly women: the study of osteoporotic fractures. J Clin Endocrinol Metab . 1998;83:2239-2243.
28. Colaianni G, Di Benedetto A, Zhu LL, et al. Regulated production of the pituitary hormone oxytocin from murine and human osteoblasts. Biochem Biophys Res Commun . 2011;411:512-515.
29. Colaianni G, Sun L, Di Benedetto A, et al. Bone marrow oxytocin mediates the anabolic action of estrogen on the skeleton. J Biol Chem . 2012;287:29159-29167.
30. Motyl KJ, Rosen CJ. Understanding leptin-dependent regulation of skeletal homeostasis. Biochimie . 2012;94:2089-2096.
31. Colli VC, Okamoto R, Spritzer PM, Dornelles RC. Oxytocin promotes bone formation during the alveolar healing process in old acyclic female rats. Arch Oral Biol . 2012;57:1290-1297.